Vicarious Surgical (NYSE:RBOT) announced today that it successfully completed an in-vivo porcine lab as it advances its ...

Adam Sachs, cofounder and CEO, of Vicarious Surgical eagerly awaited this morning’s first trade of his surgical robot company under the ticker RBOT on the New York Stock Exchange. “It’s honestly a ...

The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...

Under the agreement, the engineering partner will be responsible for a significant portion of the software development for the Vicarious robotic system.

Silicon Valley enjoys something of a monopoly these days on making the most noise in the U.S. economy. But there's been surprisingly little fanfare surrounding the latest project that seemingly all ...

Elon Musk and Mark Zuckerberg might not be able to agree about much when it comes to AI these days, but the pair do seem to see the same potential in Vicarious, a startup applying unsupervised ...

WALTHAM, Mass., October 30, 2025--(BUSINESS WIRE)--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to ...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve patient ...